• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发算法来估算 EQ-5D 并从 WHOQOL-HIV Bref 中得出健康效用:一项映射研究。

Development of algorithms to estimate EQ-5D and derive health utilities from WHOQOL-HIV Bref: a mapping study.

机构信息

Fundação Oswaldo Cruz, FIOCRUZ, Escola Nacional de Saúde Pública Sergio Arouca, Rua Leopoldo Bulhões, 1480, Manguinhos, Rio de Janeiro, RJ, ZIP 21041-210, Brazil.

Universidade Federal do Estado do Rio de Janeiro, UNIRIO, Instituto de Saúde Coletiva, Rio de Janeiro, RJ, Brazil.

出版信息

Qual Life Res. 2020 Sep;29(9):2497-2508. doi: 10.1007/s11136-020-02534-1. Epub 2020 May 25.

DOI:10.1007/s11136-020-02534-1
PMID:32451983
Abstract

PURPOSE

This study aimed to develop and evaluate different families of applicable models available for utility mapping between World Health Organization Quality of Life for HIV-abbreviated version (WHOQOL-HIV Bref) and EQ-5D-3L and to propose an optimised algorithm to estimate health utilities of people living with HIV.

METHODS

Estimation dataset was collected between July 2014 and September 2016 in a cross-sectional study including 1526 people living with HIV/Aids (PLWH) under care at the Instituto Nacional de Infectologia Evandro Chagas-FIOCRUZ, in Brazil. Data of WHOQOL-HIV Bref and EQ-5D-3L questionnaires were collected. Fisher's exact tests were used for testing WHOQOL-HIV Bref response frequencies among groups of responses to each of the five EQ-5D-3L domains. Multiple correspondence analyses (MCA) were used to inspect the relationships between both instrument responses. Different families of applicable models available for utility mapping between WHOQOL-HIV Bref and EQ-5D-3L were adjusted for the prediction of disutility.

RESULTS

Candidate models' performances using mean absolute error (MAE), mean squared error (MSE), and root mean squared error (RMSE) were similarly good, which was evidenced by the overlapping of its 95% confidence intervals of the mean tenfold cross-validation or estimated generalisation errors. However, the Hurdle Logistic-Log-Normal model was better on average according to generalisation errors both in the prediction of Brazilian utility values (MAE = 0.1037, MSE = 0.0178, and RMSE = 0.1332) and for those of the UK (MAE = 0.1476, MSE = 0.0443, and RMSE = 0.2099).

CONCLUSIONS

Mapping EQ-5D-3L responses or deriving health utilities directly from WHOQOL-HIV Bref responses can be a valid alternative for settings with no preference-based health utility data.

摘要

目的

本研究旨在开发和评估适用于世界卫生组织艾滋病毒简表生存质量量表(WHOQOL-HIV Bref)和 EQ-5D-3L 间效用映射的不同适用模型家族,并提出一种优化算法来估计艾滋病毒感染者的健康效用。

方法

估计数据集于 2014 年 7 月至 2016 年 9 月期间在巴西国家传染病学研究所 Evandro Chagas-FIOCRUZ 艾滋病毒感染者/艾滋病患者(PLWH)护理的横断面研究中收集。收集了 WHOQOL-HIV Bref 和 EQ-5D-3L 问卷的数据。Fisher 确切检验用于检验 WHOQOL-HIV Bref 对五个 EQ-5D-3L 域中每个域的反应的反应频率。多元对应分析(MCA)用于检查两种仪器反应之间的关系。调整了适用于 WHOQOL-HIV Bref 和 EQ-5D-3L 间效用映射的不同适用模型家族,以预测效用损失。

结果

使用平均绝对误差(MAE)、平均平方误差(MSE)和均方根误差(RMSE)的候选模型性能同样良好,这可以通过其 95%置信区间的平均十倍交叉验证或估计的泛化误差的重叠来证明。然而,根据英国的预测,Hurdle 逻辑正态模型在预测巴西效用值时的平均泛化误差方面(MAE=0.1037,MSE=0.0178,RMSE=0.1332)和英国的预测(MAE=0.1476,MSE=0.0443,RMSE=0.2099)都更好。

结论

从 WHOQOL-HIV Bref 反应直接映射 EQ-5D-3L 反应或推导健康效用可以成为没有偏好健康效用数据的情况下的有效替代方法。

相似文献

1
Development of algorithms to estimate EQ-5D and derive health utilities from WHOQOL-HIV Bref: a mapping study.开发算法来估算 EQ-5D 并从 WHOQOL-HIV Bref 中得出健康效用:一项映射研究。
Qual Life Res. 2020 Sep;29(9):2497-2508. doi: 10.1007/s11136-020-02534-1. Epub 2020 May 25.
2
Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.在HIV患者中对MOS-HIV与HUI3和EQ-5D-3L进行映射分析。
MDM Policy Pract. 2017 Jul 3;2(2):2381468317716440. doi: 10.1177/2381468317716440. eCollection 2017 Jul-Dec.
3
Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.将帕金森特定评分转化为健康状态效用值,以评估成本效用分析。
Patient. 2018 Dec;11(6):665-675. doi: 10.1007/s40271-018-0317-5.
4
Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study.基于映射研究从中医健康状况量表(TCM-HSS)获取 EQ-5D-3L 效用指数。
Health Qual Life Outcomes. 2022 Dec 15;20(1):164. doi: 10.1186/s12955-022-02076-9.
5
Mapping EQ-5D utility scores from the PedsQL™ generic core scales.根据儿童生活质量量表(PedsQL™)通用核心量表映射EQ-5D效用得分。
Pharmacoeconomics. 2014 Jul;32(7):693-706. doi: 10.1007/s40273-014-0153-y.
6
Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.使用多种建模方法将 FACT-B 映射到 EQ-5D-5L:来自中国乳腺癌患者的数据。
Health Qual Life Outcomes. 2019 Oct 15;17(1):153. doi: 10.1186/s12955-019-1224-8.
7
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.使用多发性硬化症影响量表来估算健康状态效用值:从 MSIS-29 版本 2 到 EQ-5D 和 SF-6D 的映射。
Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4.
8
Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients.比较非小细胞肺癌患者中EQ-5D-5L、EQ-5D-3L与欧洲癌症研究与治疗组织核心生活质量问卷(EORTC-QLQ-C30)之间的映射关系。
Health Qual Life Outcomes. 2016 Apr 12;14:60. doi: 10.1186/s12955-016-0455-1.
9
Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.将欧洲癌症研究与治疗组织生活质量核心问卷(EORTC QLQ-C30)映射到欧洲五维度健康量表(EQ-5D-3L):评估现有映射算法的外部效度。
Qual Life Res. 2016 Apr;25(4):891-911. doi: 10.1007/s11136-015-1116-2. Epub 2015 Sep 21.
10
Mapping World Health Organization Quality of Life-BREF Onto 5-Level EQ-5D in Thai Patients With Chronic Diseases.将世界卫生组织生活质量简表映射到泰国慢性病患者的 5 级 EQ-5D 上。
Value Health. 2021 Aug;24(8):1089-1094. doi: 10.1016/j.jval.2021.03.001. Epub 2021 Apr 28.